Cargando…
TRIM3 inhibits P53 signaling in breast cancer cells
BACKGROUND: Beast cancer is the most common women cancer worldwide, while two third of them are ER alpha positive breast cancer. Among the ER alpha positive breast cancer, about 80% are P53 wild type, indicating the potential tumor suppression role in ER alpha positive breast cancer. Since P53 is an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685606/ https://www.ncbi.nlm.nih.gov/pubmed/33292295 http://dx.doi.org/10.1186/s12935-020-01630-z |